For the next in our series of conditions GPs might rarely encounter, Neurology consultant Dr Clare Bolton provides an ...

The link between narcolepsy and cardiovascular disease (CVD) was strengthened by new evidence that the relationship applied ...

Nevertheless, the existing data do support such a theory: the disease is strongly associated with a T-cell receptor α gene variant, and 95% of patients with narcolepsy with cataplexy carry the ...

Eventually, I learned there was a form without cataplexy—called “narcolepsy type 2″—and it was like a lightbulb went off. During this time, I relocated from Ohio to Florida’s Gulf Coast ...

Analysts at BMO Capital Markets said Centessa’s orexin receptor agonist has “best-in-class” potential for narcolepsy, putting ...

This results in falling asleep without warning ... The difference is that type 1 narcolepsy has cataplexy, the sudden loss of muscle tone, while type 2 does not. Despite the typical depiction ...

SAN DIEGO -- AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed.

Without being properly diagnosed and treated ... For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. But increased competition is on the horizon.

Untreated, EDS is analogous to how a person without narcolepsy feels after being awake for 48-72 hours. Additional symptoms that comprise the narcolepsy symptom pentad include cataplexy ...